Apolipoprotein E ε4-dependent associations between carotenoids and cognitive decline: Findings from the MIND (Mediterranean-DASH Intervention for Neurodegenerative delay) randomized controlled trial
The American Journal of Clinical Nutrition · 2025-11 · 122 (5) · 1289-1297
DOI: 10.1016/j.ajcnut.2025.08.012 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The American Journal of Clinical Nutrition, 2025-11. Verfasst von Xiaoran Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, IL, United States; Department of Internal Medicine, Rush University Medica…. Hauptthemen laut MEDLINE: Carotenoids, Apolipoprotein E4, Cognitive Dysfunction, Diet, Mediterranean. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, Harvard T.H. Chan School of Public Health, National Institute on Aging.
Abstract (Originalsprache)
BACKGROUND: Alzheimer disease (AD) prevention is a public health priority, yet the impact of dietary carotenoids on cognitive decline, particularly in apolipoprotein E (APOE) ε4 carriers, remains unclear. OBJECTIVES: The objective of this study was to examine whether the APOE ε4 genotype modifies the relationship between blood carotenoid concentrations and global cognition. METHODS: This study was conducted within the Mediterranean-Dietary Approaches to Stop Hypertension intervention for neurodegenerative delay trial, a 3-y randomized controlled trial comparing the effects of the Mediterranean-Dietary Approaches to Stop Hypertension intervention for neurodegenerative delay diet with the usual diet on global cognition in older adults. Eligible participants were ≥65 y, had a body mass index (in kg/m2) >25, a family history of AD, suboptimal diets, and a Montreal cognitive assessment score ≥22. The primary outcome was 3-y change in global cognitive function, assessed using a validated composite cognitive score converted to standardized units (SUs). Baseline plasma carotenoid concentrations were measured in a subgroup of participants (n = 442). Mixed-effects models were used to test the interaction between APOE ε4 status and baseline carotenoid concentrations on cognitive trajectories. RESULTS: The mean age was 70.0 y for noncarriers (n = 308) and 69.4 y for APOE ε4 carriers (n = 134). Among APOE ε4 carriers, a 1-unit increment in plasma total carotenoids at baseline was associated with higher global cognitive scores [β = 0.17 SU; 95% confidence interval (CI): 0.06, 0.28 SU; P = 0.009]. Similar associations were observed for β-carotene (β = 0.13 SU; 95% CI: 0.05, 0.21 SU; P = 0.001), α-carotene (β = 0.09 SU; 95% CI: 0.02, 0.15 SU; P = 0.008), lutein plus zeaxanthin (β = 0.14 SU; 95% CI: 0.04, 0.25 SU; P = 0.008), lycopene (β = 0.17 SU; 95% CI: 0.07, 0.28 SU; P = 0.005), and β-cryptoxanthin (β = 0.13 SU; 95% CI: 0.05, 0.21 SU; P = 0.03). Associations in noncarriers were weaker or nonsignificant. CONCLUSIONS: Higher plasma carotenoid concentrations were associated with slower cognitive decline in APOE ε4 carriers, potentially mitigating genetic risk. This trial was registered at clinicaltrials.gov as NCT02817074.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, IL, United States; Department of Internal Medicine, Rush University Medical Center, Chicago, IL, United States. Electronic address: Xiaoran_Liu@…
- Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
- Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, IL, United States; Department of Internal Medicine, Rush University Medical Center, Chicago, IL, United States.
- Department of Clinical Nutrition and Department of Family and Preventive Medicine, Rush University Medical Center, Chicago, IL, United States.
- Department of Medicine, University of Southern California, Los Angeles, CA, Unites States; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, University of Southern California, Los An…
- Rush Alzheimer's Disease Center, Chicago, IL, Unites States; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, Unites States.
Förderung
- NIA NIH HHS
- Harvard T.H. Chan School of Public Health
- National Institute on Aging
- Alzheimer's Association
- National Institutes of Health
- National Institute of Standards and Technology
Zitieren
APA
Liu, X., Sacks, F. M., Beck, T., Tangney, C. C., Willett, W. C., Yassine, H., Dhana, K., Aggarwal, N. T., Rajan, K. B., & Barnes, L. L. (2025). Apolipoprotein E ε4-dependent associations between carotenoids and cognitive decline: Findings from the MIND (Mediterranean-DASH Intervention for Neurodegenerative delay) randomized controlled trial. The American Journal of Clinical Nutrition, 122(5), 1289-1297. https://doi.org/10.1016/j.ajcnut.2025.08.012
Vancouver
Liu X, Sacks FM, Beck T, Tangney CC, Willett WC, Yassine H, et al. Apolipoprotein E ε4-dependent associations between carotenoids and cognitive decline: Findings from the MIND (Mediterranean-DASH Intervention for Neurodegenerative delay) randomized controlled trial. The American Journal of Clinical Nutrition. 2025;122(5):1289-1297. doi:10.1016/j.ajcnut.2025.08.012
BibTeX
@article{Liu2025,
author = {Liu, Xiaoran and Sacks, Frank M and Beck, Todd and Tangney, Christy C and Willett, Walter C and Yassine, Hussein and Dhana, Klodian and Aggarwal, Neelum T and Rajan, Kumar B and Barnes, Lisa L},
title = {Apolipoprotein E ε4-dependent associations between carotenoids and cognitive decline: Findings from the MIND (Mediterranean-DASH Intervention for Neurodegenerative delay) randomized controlled trial},
journal = {The American Journal of Clinical Nutrition},
year = {2025},
volume = {122},
number = {5},
pages = {1289--1297},
doi = {10.1016/j.ajcnut.2025.08.012}
}
EUVIMED